Ohio Announces $5 Million in Grants to Support Pediatric Cancer Research

"Pediatric cancer research is vital to improve survival rates and understand the unique biology of childhood cancers," said Governor DeWine. "Funding research that is driven by Ohio’s best and brightest children’s hospitals and researchers demonstrates once again that Ohio is a leader in caring for, prioritizing, and supporting children and families."

Established as part of the state fiscal year 2026-2027 state biennial budget, this grant is awarded to the following Ohio-based healthcare and non-profit research organizations:

• Cincinnati Children’s Hospital Medical Center
• Cleveland Clinic 
• Dayton Children’s Hospital
• Maple Tree Cancer Alliance
• Research Institute at Nationwide Children’s Hospital

“Investing in pediatric cancer research is one of the many ways Governor DeWine continues to prioritize Ohio’s children,” said Kara Wente, director of the Ohio Department of Children and Youth. “This funding will advance critical research that helps Ohio’s children grow, thrive, and reach their full potential.”

“Today, better than 80% of Ohio children diagnosed with cancer will survive these cancers, up from around 20% in the 1970s,” said Bruce Vanderhoff, MD, MBA, director of the Ohio Department of Health.  “We’ve come a long way, but there’s still a lot of work to do. These grant dollars will advance research that helps pediatric cancer survivors live longer.”

The Research Institute at Nationwide Children’s Hospital will test a blood-based liquid biopsy as a new way to detect pediatric cancers earlier and monitor high-risk children without relying on invasive procedures or frequent MRI/CT scans.

“We are grateful for the funding from the Ohio Department of Children and Youth and for Governor DeWine’s unfailing support to improve child health,” said Dennis Durbin, MD, MSCE, president, Abigail Wexner Research Institute at Nationwide Children’s Hospital. “Our investigators, Dr. Samara Potter and Dr. Katherine Miller, have developed an assay using advanced sequencing to detect tumor DNA through a simple blood draw. This funding will expand their research into a more cost-effective and less invasive test for children and young adults with a high risk of developing cancer or a recurrence of cancer, leading to improved outcomes for these patients.”

To ensure these funds make the greatest impact, DCY has formed a work group to provide feedback on grant-funded research projects and help guide this important work. The Pediatric Cancer Research Work Group brings together Ohioans with a variety of perspectives and experiences, including researchers, clinicians, advocates, stakeholders, and family members. The Work Group convened in Columbus on December 4, 2025, for its first session to hear presentations by each of the grant awardees and provide feedback. The group will continue to meet over the next two years to hear progress reports from grantees.